NCT05516576View on ClinicalTrials.gov

Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial

NARecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

December 31, 2028

Conditions

Diabetes Mellitus, Type 2Obesity

Interventions

DEVICE

endomina®

Endoscopic gastroplasty

Trial Locations (1)

38043

RECRUITING

Chu Grenoble Alpes, La Tronche

All Listed Sponsors

collaborator

Endo Tools Therapeutics S.A.

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT05516576 - Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial | Biotech Hunter | Biotech Hunter